Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Posaconazole","url":"https:\/\/www.ortaakarsu.net\/?page_id=12395","facts":[{"label":"Active ingredient \/ generic name","value":"posaconazole"},{"label":"ATC code","value":"J02AC04"}]},{"title":"Riociguat","url":"https:\/\/www.ortaakarsu.net\/?page_id=12407","facts":[{"label":"Active ingredient \/ generic name","value":"riociguat"},{"label":"ATC code","value":"C02KX05"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"Current document checked 2026-11-02; revision date not printed; 4.5 Strong multi-pathway CYP and P-gp\/BCRP inhibitors"}],"sources":[{"label":"Adempas \u2014 EMA product information","url":"https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/adempas-epar-product-information_en.pdf"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:31283","available":true}}